CAFs-derived lysyl oxidase (LOX) functions as the initiator of collagen crosslinking in overexpression in several cancers, such as gastric and breast cancer and promoting cancer cell survival, epithelial–mesenchymal transition (EMT), metastasis, invasion, angiogenesis, and drug resistance [35]. The gene discussed is LOX; the disease is breast carcinoma.